Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer (Breast 41)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01532960
Recruitment Status : Terminated (Futility for immune responses to the vaccine. Also, a component of study drug was in short supply.)
First Posted : February 15, 2012
Last Update Posted : August 15, 2016
Information provided by (Responsible Party):
Craig L Slingluff, Jr, University of Virginia

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2015
  Actual Study Completion Date : September 2015